Highlights and Quick Summary
- Net Current Asset Value for the quarter ending September 30, 2022 was $473 Million (a -15.76% decrease compared to previous quarter)
- Year-over-year quarterly Net Current Asset Value decreased by -24.33%
- Annual Net Current Asset Value for 2021 was $625 Million (a 511.8% increase from previous year)
- Annual Net Current Asset Value for 2020 was $102 Million (a -138.91% decrease from previous year)
- Annual Net Current Asset Value for 2019 was $-263 Million (a 92.93% increase from previous year)
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Current Asset Value of Beam Therapeutics Inc.
Most recent Net Current Asset Valueof BEAM including historical data for past 10 years.Interactive Chart of Net Current Asset Value of Beam Therapeutics Inc.
Beam Therapeutics Inc. Net Current Asset Value for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $473.14 | $561.68 | $615.15 | – |
| 2021 | $625.29 | $638.68 | $333.47 | $243.77 | $625.29 |
| 2020 | $102.21 | $130.51 | $165.68 | $198.39 | $102.21 |
| 2019 | $-262.66 | $0.0 | $0.0 | $0.0 | $-262.66 |
| 2018 | – | – | – | $-136.14 | $-136.14 |
| 2017 | – | – | – | – | $-5.0 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology